EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 182 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2017. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $72,000 | -55.6% | 1,500 | -53.1% | 0.00% | -55.6% |
| Q1 2019 | $162,000 | -57.9% | 3,200 | -50.8% | 0.01% | -62.5% |
| Q4 2018 | $385,000 | -51.3% | 6,500 | -45.8% | 0.02% | -38.5% |
| Q3 2018 | $790,000 | +22.3% | 12,000 | -6.2% | 0.04% | +14.7% |
| Q2 2018 | $646,000 | -11.7% | 12,800 | -7.9% | 0.03% | -15.0% |
| Q1 2018 | $732,000 | +13.3% | 13,900 | 0.0% | 0.04% | +14.3% |
| Q4 2017 | $646,000 | -10.8% | 13,900 | -22.3% | 0.04% | -10.3% |
| Q3 2017 | $724,000 | +14.7% | 17,900 | -3.8% | 0.04% | +8.3% |
| Q2 2017 | $631,000 | -1.3% | 18,600 | -15.5% | 0.04% | -2.7% |
| Q1 2017 | $639,000 | -9.1% | 22,000 | +2.8% | 0.04% | -15.9% |
| Q4 2016 | $703,000 | +248.0% | 21,400 | +197.2% | 0.04% | +214.3% |
| Q3 2016 | $202,000 | 0.0% | 7,200 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $202,000 | – | 7,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
| Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
| AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
| SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |